Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

GERON CORPORATION (GERN)

18
Delayed Quote. Delayed Nasdaq - 05/22 04:00:00 pm
3.95 USD   -1.74%
05/11 GERON : The Shuman Law Firm : Investigates Geron Corp.
05/05 GERON : NASDAQ:GERN) Investor Alert: Investigation over Potential Wr..
04/30 GERON : reports 1Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
3.88(c) 3.76(c) 4.19(c) 4.02(c) 3.95(c) Last
977 547 2 082 667 6 274 695 2 108 712 1 333 552 Volume
-0.26% -3.09% +11.44% -4.06% -1.74% Change
More quotes
Financials ($)
Sales 2015 27,9 M
EBIT 2015 -8,74 M
Net income 2015 -13,6 M
Debt 2015 -
Yield 2015 -
Sales 2016 1,23 M
EBIT 2016 -19,0 M
Net income 2016 -40,6 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 22,8x
Capi. / Sales 2016 518x
Capitalization 636 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
05/11 GERON : The Shuman Law Firm : Investigates Geron Corp.
05/06 GERON : Harwood Feffer LLP Announces Investigation of Geron Corporation
05/05 GERON : NASDAQ:GERN) Investor Alert: Investigation over Potential Wrongdoing
04/30 GERON : reports 1Q loss
04/30 Geron Corporation Reports First Quarter 2015 Financial Results and Recent Eve..
04/29 GERON : Harwood Feffer LLP : Announces Investigation of Geron Corporation
04/28 GERON : Stock Alert: Schubert Firm Investigates Company's Top Executives
04/27 Geron to Present at the Bank of America Merrill Lynch Healthcare Conference
More news
Sector news : Bio Therapeutic Drugs
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
05/21 ABBVIE : specifies breakdown of $21 billion Pharmacyclics deal
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/20 Some Answers From Dr. Scarlett, CEO Of Geron
05/18 Asterias Biotherapeutics' Stem Cell Program Is Dead On Arrival
05/01 Geron revenues up 13% in Q1
04/30 Geron EPS in-line, beats on revenue
04/30 AIM's Tory Williams Unites Patient Advocacy With Stem Cell Funding In The Dee..


Comments 
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions